The aim of this study was to assess the serum concentration of
high-sensitivity C-reactive protein (
hs-CRP) in children with
nephrotic syndrome (NS) treated with
prednisone and
cyclosporine A (CyA). Patients were divided into three groups: (I) 20 NS children (aged 4-14 years) in relapse and examined twice, (A) before treatment and (B) after
proteinuria regression (a 3-4 week course of
prednisone therapy); (II) 20 children with
steroid-dependent or
steroid-resistant NS, treated with CyA, also examined twice, (D) before treatment with CyA, (E) 6 months after
therapy. A control group (C) consisted of 20 healthy children. Serum
hs-CRP level was determined by a nephelometric method with a Behring Nephelometer 100 Analyzer, Dade Behring. The results showed that median
hs-CRP concentration was the highest in children with relapsing
steroid-sensitive NS before treatment (IA). After
proteinuria regression (IB), the
hs-CRP level had decreased and did not differ from that of healthy controls (C) (P>0.05). In group II, before CyA administration (IID), the level of
hs-CRP was normal, but it had increased after 6 months of treatment (IIE) up to a level six-times higher than that of the control group (P<0.01). We concluded that, in children with
steroid-sensitive nephrotic syndrome in relapse, the serum
hs-CRP level is increased but returns to normal after 3-4 weeks of
glucocorticoid treatment. In children chronically treated with CyA due to NS, serum
hs-CRP level increases significantly during the
therapy.